Supplementation with active hexose correlated compound increases survival following infectious challenge in mice

Nutrition Reviews

Volumn 66, Issue 9, 2008, Pages 526-531

  Ritz, Barry W ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

Infection; Influenza; MRSA; Mushroom; Nutraceutical

Indexed keywords

ACTIVE HEXOSE CORRELATED COMPOUND; HEXOSE; UNCLASSIFIED DRUG;

AVIAN INFLUENZA; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CANDIDA ALBICANS; CANDIDIASIS; ENTEROBACTER INFECTION; EXPERIMENTAL MOUSE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OPPORTUNISTIC INFECTION; PROVOCATION TEST; PSEUDOMONAS AERUGINOSA; REVIEW; SUPPLEMENTATION; SURVIVAL; SWISS WEBSTER MOUSE; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; CANDIDIASIS; INFECTION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; KLEBSIELLA INFECTIONS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; OPPORTUNISTIC INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; POLYSACCHARIDES; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE;

AVIAN INFLUENZA VIRUS; BASIDIOMYCOTA; CANDIDA ALBICANS; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS; ORTHOMYXOVIRIDAE; PSEUDOMONAS AERUGINOSA;

EID: 50249136089     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00085.x     Document Type: Review

References (32)

1. Lindequist U, Niedermeyer THJ, Julich W-D. The pharmacological potential of mushrooms. eCAM. 2005 2 : 285 299.
2. Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld G. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection. Am J Surg. 2008 195 : 537 545.
3. Matsushita K, Kuramitsu Y, Ohiro Y, et al. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs. 1998 9 : 343 350.
4. Matsui Y, Uhara J, Satoi S, et al. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. J Hepatol. 2002 37 : 78 86.
5. Brown GD, Herre J, Williams DL, Willment JA, Marshall ASJ, Gordon S. Dectin-1 mediates the biological effects of ß-glucans. J Exp Med. 2003 197 : 1119 1124.
6. Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol. 2004 97 : 1437 1444.
7. Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in rat. Endocr Regul. 2000 34 : 181 188.
8. Wang S, Wakame K, Igarashi Y, et al. Beneficial effects of active hexose correlated compound (AHCC) on immobilization stress in rat. Dokkyo J Med Sci. 2001 28 : 559 565.
9. Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother. 2006 55 : 1258 1266.
10. Ghoneum M, Wimbley M, Salem F, McKlain A, Attallah N, Gill G. Immunomodulatory and anticancer effects of active hexose correlated compound (AHCC). Int J Immunother. 1995 11 : 23 28.
11. Uno K, Kosuna K, Sun B, et al. Active hexose correlated compound (AHCC) improves immunological parameters and performance status of patients with solid tumors. Biotherapy (Japan). 2000 14 : 303 309.
12. Ye SF, Ichimura K, Wakame K, Ohe M. Suppressive effects of active hexose correlated compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci. 2003 74 : 593 602.
13. Wang S, Ichimura K, Wakame K. Preventive effects of active hexose correlated compound (AHCC) on oxidative stress induced by ferric nitrilotriacetate in the rat. Dokkyo J Med Sci. 2001 28 : 745 752.
14. Sun B, Mukoda T, Miura T, et al. Anti-tumor effects of genestein combined polysaccharide (GCP) and active hexose correlated compound (AHCC). Biotherapy (Japan). 2001 15 : 379 382.
15. Ritz BW, Nogusa S, Ackerman EA, Gardner EM. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J Nutr. 2006 136 : 2868 2873.
16. Fujii H, Nishioka H, Wakame K, Sun B. Nutritional food active hexose correlated compound (AHCC) enhances resistance against bird flu. Jap J Complemen Altern Med. 2007 1 : 37 39.
17. Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G. Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol. 2003 95 : 491 496.
18. Ishibashi H, Ikeda T, Tansho S, et al. Prophylactic efficacy of basidiomycetes preparation AHCC against lethal opportunistic infections in mice. J Pharmacol (Japan). 2000 120 : 715 719.
19. Mestas J, Hughes CCW. Of mice and men: differences between mouse and human immunology. J Immunol. 2004 172 : 2731 2738.
20. Burleson GR, Burleson FG. Influenza virus host resistance model. Methods. 2007 41 : 31 37.
21. Aviles H, O'Donnell P, Sun B, Sonnenfeld G. Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection. Surg Infect. 2006 7 : 527 535.
22. Update: influenza activity - United States, 2004-05 season. MMWR 2004 54 : 328.
23. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2003 292 : 1333 1340.
24. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003 289 : 179 186.
25. th eds. Philadelphia, PA : Lippincott Williams & Wilkins, 2001.
26. Briedis DJ. Orthomyxoviruses. In : Acheson NH, ed. Fundamentals of Molecular Virology. Hoboken, NJ : John Wiley & Sons, 2007.
27. th eds. Philadelphia, PA : Lippincott Williams & Wilkins, 2001.
28. Beigel JH, Farrar J, Han AM, et al, for the Writing Committee of the World Health Organization Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. New Engl J Med. 2005 353 : 1374 1385.
29. Normile D. Flu virus research yields results but no magic bullet for pandemic. Science. 2008 29 : 1178 1179.
30. World Health Organization. Avian Influenza. Available at: http://www.who.int/topics/avian_influenza. Accessed June 2007.
31. Centers for Disease Control and Prevention. Avian Influenza (Bird Flu). Available at: http://www.cdc.gov/flu/avian. Accessed January 2008.
32. Guidance for industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), July 2005. Available at: http://www.fda.gov/cder/guidance/index.htm. Accessed July 2008.